---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-24-048475"
form_type: "8-K"
ticker: "RCKT"
cik: "0001281895"
company_name: "ROCKET PHARMACEUTICALS, INC."
filed_at: "2024-12-05T23:59:59+00:00"
generated_at: "2026-05-29T06:59:10.337932+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Rocket Pharma GM Commercial Affairs Mark White resigns effective Jan 1

## Summary
- Mark White resigns as General Manager, Commercial Affairs, effective January 1, 2025.
- No successor has been named.
- The company did not disclose a reason for the resignation.

## SEC filing metadata
- accession: 0001140361-24-048475
- form_type: 8-K
- ticker: RCKT
- cik: 0001281895
- company_name: ROCKET PHARMACEUTICALS, INC.
- filed_at: 2024-12-05T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1281895/000114036124048475/0001140361-24-048475-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1281895/000114036124048475/ef20039631_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-24-048475
- JSON: https://secwatch.observer/filing/0001140361-24-048475.json
- Plain text: https://secwatch.observer/filing/0001140361-24-048475.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.